/Pfizer%20Inc_%20logo%20sign-by%20JHVEPhoto%20via%20iStock.jpg)
With a market cap of $138.2 billion, Pfizer Inc. (PFE) is a leading global biopharmaceutical company headquartered in New York City. Founded in 1849, Pfizer discovers, develops and manufactures medicines and vaccines across a broad range of therapeutic areas, including oncology, immunology, rare diseases, cardiology, endocrinology and vaccines.
Shares of this pharmaceutical giant have underperformed the broader market over the past year. PFE has declined 21% over this time frame, while the broader S&P 500 Index ($SPX) has rallied nearly 17.1%. In 2025, PFE stock is down 8.4%, compared to SPX’s 8.6% rise on a YTD basis.